editor@jprims.in
9343055451
e-ISSN: 3049-1681
logo

Journal of Pharmaceutical Research and Integrated Medical Sciences

📢 Latest Update: New special issue call for papers on "Pharmaceutical Research and Integrated Medical Sciences" - Submit by March 31, 2026

📢 Latest Update: New special issue call for papers on "Pharmaceutical Research and Integrated Medical Sciences" - Submit by March 31, 2026

Volume 3, Issue 1 - 2026 (JPRIMS, Vol-3, Issue-01, Jan.-2026)

Volume 3 Issue 1 Cover

Issue Details:

Volume 3 Issue 1
Published:Invalid Date

Editorial: JPRIMS, Vol-3, Issue-01, Jan.-2026

Welcome to the 2026 issue of Journal of Pharmaceutical Research and Integrated Medical Sciences. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr. Arpan Kumar Tripathi
Editor-in-Chief
Journal of Pharmaceutical Research and Integrated Medical Sciences

Articles in This Issue

Showing 2 of 2 articles
Research PaperID: jprims-00000208

Optimizing Healthcare Through Digital Twin Technology: Advancements, Challenges, and Future Prospects, A Meta-Analysis

D.Lalitha Sree Vani Vani, Pranusha Pranusha, B.Indraja Indraja, K.Sampath Kumar

The application of digital twin technology in healthcare has emerged as a significant advancement, offering new possibilities for personalized medicine, surgical planning, and healthcare system optimization. By creating real-time, data-driven virtual models of patients, organs, and hospital environments, digital twins enable precise simulations, predictive analytics, and personalized treatment strategies. This review and meta-analysis evaluate the role of digital twins in improving clinical decision-making, patient outcomes, and operational efficiency while also addressing the technical, ethical, and regulatory challenges that hinder their widespread adoption. The analysis synthesizes data from studies examining digital twins in disease modeling, surgical rehearsals, and hospital resource management, highlighting their ability to enhance patient-specific interventions and optimize healthcare workflows. The results suggest that digital twins significantly improve diagnostic accuracy, treatment efficacy, and hospital efficiency, demonstrating their potential as transformative tools in modern medicine. However, challenges such as data integration complexities, patient privacy concerns, computational demands, and regulatory uncertainties must be addressed to ensure reliable implementation. This study underscores the importance of further research, cross-disciplinary collaboration, and the establishment of standardized regulatory frameworks to facilitate the responsible integration of digital twin technology in healthcare. With continued advancements and appropriate safeguards, digital twins can contribute to more precise, efficient, and patient-centered healthcare delivery, paving the way for a new era of medical innovation.

Colon-targeted drug delivery,PLGA nanoparticles,Eudragit S100-coated tablets,alginate hydrogel microspheres,5-Fluorouracil (5-FU),pH-dependent release,+3 more
12,270 views
3,634 downloads

Contributors:

 D.Lalitha Sree Vani Vani
,
 Pranusha Pranusha
,
 B.Indraja Indraja
,
 K.Sampath Kumar
Research PaperID: jprims-00000209

Kawasaki Disease “Unmasked”: A Case Study from Fever to Full Recovery

Srikumar Chakravarthi, Ranjith Karthekeyan Karthekeyan, Rajan Rajabalaya Rajabalaya, Mohammad Nazmul Hasan Maziz Maziz, Yong Lit Chen Chen

A 2-year-old boy presented to the paediatric emergency department with a 5-day history of persistent high fever reaching 40°C, marked irritability, reduced oral intake, and non-productive cough. The child's mother reported onset of symptoms following a minor upper respiratory infection two weeks earlier, initially managed at home with oral paracetamol and later with oral antibiotics (amoxicillin) prescribed by a primary care physician, which failed to resolve the fever or other emerging symptoms. On examination, the child exhibited bilateral non-exudative conjunctival injection, strawberry tongue with red cracked lips, anterior cervical lymphadenopathy (right sided, 2 cm node), polymorphous erythematous rash across the trunk and extremities sparing the diaper area, and indurative oedema of the hands and feet. These findings fulfilled the diagnostic criteria for complete Kawasaki disease (KD), prompting immediate hospital admission for further evaluation and treatment.

Digital Twin TechnologyPersonalized MedicineSurgical PlanningHealthcare OptimizationPredictive AnalyticsPatient-Specific Modelling+4 more
12,332 views
3,710 downloads

Contributors:

 Srikumar Chakravarthi
,
 Ranjith Karthekeyan Karthekeyan
,
 Rajan Rajabalaya Rajabalaya
,
 Mohammad Nazmul Hasan Maziz Maziz
,
 Yong Lit Chen Chen